Request for Covid-19 Impact Assessment of this Report

Healthcare

Global Biochips Market Size study, by Type (DNA Chips, Lab-On-A-Chip, Protein Chips, Other Arrays) By Fabrication Technology (Microarrays, Microfluidics) By End User( Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, Academic & Research Institutes, Others) and Regional Forecasts 2019-2026

  • BIZ3510818
  • 200 Pages
  • February 2020
  • Healthcare
Download Sample    Get Discount   
 
Global Biochips Market is valued approximately USD 12.7 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 18.4% over the forecast period 2019-2026.

Biochips are miniaturized therapeutic devices utilized within molecular research laboratory to perform real-time biological reactions. Biochips are used for the screening of new drugs which could offer various benefits and evaluate the benefits and risk of pharmaceuticals compounds. biochip have its wide application in DNA applications such as gene expression, SNP (Single nucleotide polymorphisms) genotyping, cancer diagnosis & treatment, genomics and other. Biochips empower enormously parallel sub-atomic investigations to be done in a scaled down configuration with a high throughput. Rising incidences & treatment of cancer is the key driver for the growth of global biochip market. As rising incidences of cancer is anticipated to the rise in the demand of detection techniques. According to the World Health Organizations cancer is among the leading cause of mortality and morbidity globally that accounts for 8.8 million deaths globally in 2015, which is around one third of the total number of deaths. According to the American cancer Society by 2030, the global burden is anticipated to grow by 21.7 million new cancer cases and 13 million cancer deaths. Apart from this, increasing government funding, growth in personalized medicines and technical advances are further contributing towards market growth. However, knowledge constraint with respect to technical know-how impedes the growth of the market over the forecast period of 2019-2026.

The regional analysis of global Biochips market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to high research & development investment in the pharmaceutical & biotechnology sector, coupled with the rising market demand for precision medicine. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as owing to presence of large population base, increase in disposable income, and improvement in patient awareness about biochips would create lucrative growth prospects for the Biochips market across Asia-Pacific region.

Major market player included in this report are:

Abbott Laboratories

Agilent Technologies, Inc.

Perkinelmer, Inc.

Fluidigm Corporation

Illumina, Inc.

GE Healthcare

Bio-Rad Laboratories Inc.

Cepheid Inc.

Thermo Fisher Scientific, Inc.

Roche Diagnostics

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

DNA Chips

Lab-On-A-Chip

Protein Chips

Other Arrays

By Fabrication Technology:

Microarrays

Microfluidics

By End User

Biotechnology and Pharmaceutical Companies

Hospitals and Diagnostics Centers

Academic & Research Institutes

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

Asia Pacific

China

India

Japan

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017

Base year – 2018

Forecast period – 2019 to 2026

Target Audience of the Global Biochips Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Chapter 1. Executive Summary

1.1. Market Snapshot

1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)

1.2.1. Biochips Market, by Region, 2017-2026 (USD Billion)

1.2.2. Biochips Market, by Type, 2017-2026 (USD Billion)

1.2.3. Biochips Market, by Fabrication Technology, 2017-2026 (USD Billion)

1.2.4. Biochips Market, by End User, 2017-2026 (USD Billion)

1.3. Key Trends

1.4. Estimation Methodology

1.5. Research Assumption

Chapter 2. Global Biochips Market Definition and Scope

2.1. Objective of the Study

2.2. Market Definition & Scope

2.2.1. Scope of the Study

2.2.2. Industry Evolution

2.3. Years Considered for the Study

2.4. Currency Conversion Rates

Chapter 3. Global Biochips Market Dynamics

3.1. Biochips Market Impact Analysis (2018-2026)

3.1.1. Market Drivers

3.1.2. Market Challenges

3.1.3. Market Opportunities

Chapter 4. Global Biochips Market Industry Analysis

4.1. Porter’s 5 Force Model

4.1.1. Bargaining Power of Suppliers

4.1.2. Bargaining Power of Buyers

4.1.3. Threat of New Entrants

4.1.4. Threat of Substitutes

4.1.5. Competitive Rivalry

4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)

4.2. PEST Analysis

4.2.1. Political

4.2.2. Economical

4.2.3. Social

4.2.4. Technological

4.3. Investment Adoption Model

4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Biochips Market, by Type

5.1. Market Snapshot

5.2. Global Biochips Market by Type, Performance - Potential Analysis

5.3. Global Biochips Market Estimates & Forecasts by Type 2016-2026 (USD Billion)

5.4. Biochips Market, Sub Segment Analysis

5.4.1. DNA Chips

5.4.2. Lab-On-A-Chip

5.4.3. Protein Chips

5.4.4. Other Arrays

Chapter 6. Global Biochips Market, by Fabrication Technology

6.1. Market Snapshot

6.2. Global Biochips Market by Fabrication Technology, Performance - Potential Analysis

6.3. Global Biochips Market Estimates & Forecasts by Fabrication Technology 2016-2026 (USD Billion)

6.4. Biochips Market, Sub Segment Analysis

6.4.1. Microarrays

6.4.2. Microfluidics

Chapter 7. Global Biochips Market, by End User

7.1. Market Snapshot

7.2. Global Biochips Market by End User, Performance - Potential Analysis

7.3. Global Biochips Market Estimates & Forecasts by End User 2016-2026 (USD Billion)

7.4. Biochips Market, Sub Segment Analysis

7.4.1. Biotechnology and Pharmaceutical Companies

7.4.2. Hospitals and Diagnostics Centers

7.4.3. Academic & Research Institutes

7.4.4. Other End Users

Chapter 8. Global Biochips Market, Regional Analysis

8.1. Biochips Market, Regional Market Snapshot

8.2. North America Biochips Market

8.2.1. U.S. Biochips Market

8.2.1.1. Type breakdown estimates & forecasts, 2016-2026

8.2.1.2. Fabrication Technology breakdown estimates & forecasts, 2016-2026

8.2.1.3. End user breakdown estimates & forecasts, 2016-2026

8.2.2. Canada Biochips Market

8.3. Europe Biochips Market Snapshot

8.3.1. U.K. Biochips Market

8.3.2. Germany Biochips Market

8.3.3. Rest of Europe Biochips Market

8.4. Asia-Pacific Biochips Market Snapshot

8.4.1. China Biochips Market

8.4.2. India Biochips Market

8.4.3. Japan Biochips Market

8.4.4. Rest of Asia Pacific Biochips Market

8.5. Latin America Biochips Market Snapshot

8.5.1. Brazil Biochips Market

8.5.2. Mexico Biochips Market

8.6. Rest of The World Biochips Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies

9.2. Company Profiles

9.2.1. Abbott Laboratories

9.2.1.1. Key Information

9.2.1.2. Overview

9.2.1.3. Financial (Subject to Data Availability)

9.2.1.4. Product Summary

9.2.1.5. Recent Developments

9.2.2. Agilent Technologies, Inc.

9.2.3. Perkinelmer, Inc.

9.2.4. Fluidigm Corporation

9.2.5. Illumina, Inc.

9.2.6. GE Healthcare

9.2.7. Bio-Rad Laboratories Inc.

9.2.8. Cepheid Inc.

9.2.9. Thermo Fisher Scientific, Inc.

9.2.10. Roche Diagnostics

Chapter 10. Research Process

10.1. Research Process

10.1.1. Data Mining

10.1.2. Analysis

10.1.3. Market Estimation

10.1.4. Validation

10.1.5. Publishing

10.2. Research Attributes

10.3. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL BIOCHIPS MARKET

TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL BIOCHIPS MARKET

TABLE 3. GLOBAL BIOCHIPS MARKET, REPORT SCOPE

TABLE 4. YEARS CONSIDERED FOR THE STUDY

TABLE 5. EXCHANGE RATES CONSIDERED

TABLE 6. GLOBAL BIOCHIPS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)

TABLE 7. GLOBAL BIOCHIPS MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD BILLION)

TABLE 8. GLOBAL BIOCHIPS MARKET ESTIMATES & FORECASTS BY FABRICATION TECHNOLOGY 2016-2026 (USD BILLION)

TABLE 9. GLOBAL BIOCHIPS MARKET ESTIMATES & FORECASTS BY END USER 2016-2026 (USD BILLION)

TABLE 10. GLOBAL BIOCHIPS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 11. GLOBAL BIOCHIPS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 12. GLOBAL BIOCHIPS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 13. GLOBAL BIOCHIPS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 14. GLOBAL BIOCHIPS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 15. GLOBAL BIOCHIPS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 16. GLOBAL BIOCHIPS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 17. GLOBAL BIOCHIPS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 18. GLOBAL BIOCHIPS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 19. GLOBAL BIOCHIPS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 20. GLOBAL BIOCHIPS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 21. GLOBAL BIOCHIPS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 22. GLOBAL BIOCHIPS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 23. GLOBAL BIOCHIPS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 24. GLOBAL BIOCHIPS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 25. GLOBAL BIOCHIPS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 26. GLOBAL BIOCHIPS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 27. GLOBAL BIOCHIPS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 28. GLOBAL BIOCHIPS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 29. GLOBAL BIOCHIPS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 30. U.S. BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 31. U.S. BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 32. U.S. BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 33. U.S. BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 34. CANADA BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 35. CANADA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 36. CANADA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 37. CANADA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 38. UK BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 39. UK BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 40. UK BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 41. UK BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 42. GERMANY BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 43. GERMANY BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 44. GERMANY BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 45. GERMANY BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 46. ROE BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 47. ROE BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 48. ROE BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 49. ROE BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 50. CHINA BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 51. CHINA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 52. CHINA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 53. CHINA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 54. INDIA BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 55. INDIA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 56. INDIA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 57. JAPAN BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 58. JAPAN BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 59. JAPAN BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 60. JAPAN BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 61. ROAPAC BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 62. ROAPAC BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 63. ROAPAC BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 64. ROAPAC BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 65. BRAZIL BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 66. BRAZIL BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 67. BRAZIL BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 68. BRAZIL BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 69. MEXICO BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 70. MEXICO BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 71. MEXICO BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 72. MEXICO BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 73. ROLA BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 74. ROLA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 75. ROLA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 76. ROLA BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 77. ROW BIOCHIPS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)

TABLE 78. ROW BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 79. ROW BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

TABLE 80. ROW BIOCHIPS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2020 World Blood Typing, Grouping and Infectious Disease NAT Screening Market in 68 Countries: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review

This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.

The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...

  • Publish Date: March 2, 2020
  • $0
Hearing Aids Market in India 2011

Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...

  • Publish Date: March 10, 2011
  • $950
Cardiac Pacemaker Market in India 2011

The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...

  • Publish Date: July 18, 2011
  • $950